- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
A
ABCL
Abcellera Biologics Inc.
3.04
-0.18-5.59%After Hours: 3.060 +0.020 +0.65%19:48 02/20 EST
OPEN/PREV CLOSE3.160/3.220
TODAY RANGE2.965-3.180
VOL4.70M
MARKET CAP909.98M
52 WEEK RANGE1.891-6.52
AVG VOL (3M)4.18M
% TURNOVER1.57%
TURNOVER--
P/E (TTM)-5.2741
% RANGE6.37%
EPS(TTM)-0.5764
P/E(FORWARD)-4.9836
P/B0.9429
BVPS3.224
DIVIDEND--
P/S31.18
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP700.97M
SHARES OUTSTANDING299.34M
NEXT EARNINGS02/25-03/02
FREE FLOAT230.58M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·02/12 11:04
3 Promising Penny Stocks With At Least $600M Market Cap
Reuters·02/11 21:06
AbCellera Biologics to Present at Major Investor Conferences
Simply Wall St·02/05 20:28
Is AbCellera (ABCL) Trading Its Platform Identity For Higher-Stakes Clinical Ambitions?
Seeking Alpha·02/03 20:06
OpenAI considers backing AI-led drug discovery firms: report
Simply Wall St·01/30 08:38
AbCellera Advances ABCL635 Menopause Candidate As Shares Trade Below Targets
Simply Wall St·01/24 09:30
Advancing Non-Hormonal Menopause Drug Into Phase 2 Could Be A Game Changer For AbCellera (ABCL)
Reuters·01/22 21:05
Abcellera Biologics Inc. to Announce Full Year 2025 Financial Results
Simply Wall St·01/22 11:42
A Look At AbCellera Biologics (ABCL) Valuation After ABCL635 Advances Into Phase 2 Trial
Simply Wall St·01/17 01:47
Is AbCellera (ABCL) Quietly Recasting Its Platform As A Menopause-Focused Drug Developer?
Reuters·01/12 15:40
BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners
TipRanks·01/12 14:36
AbCellera doses first patients in Phase 2 portion of ABCL635 trial
Reuters·01/12 14:11
BUZZ-AbCellera rises as it starts mid-stage trial for menopause drug
Same Industry
Name/Symbol
Change%
Price